Ependymoma classification

Jump to: navigation, search

Ependymoma Microchapters

Home

Patient Information

Overview

Classification

Historical Perspective

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Differentiating Ependymoma from other Diseases

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Staging

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ependymoma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ependymoma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ependymoma classification

CDC on Ependymoma classification

Ependymoma classification in the news

Blogs on Ependymoma classification</small>

Directions to Hospitals Treating Ependymoma

Risk calculators and risk factors for Ependymoma classification

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Classification

  • About 85% of ependymomas are benign myxopapillary ependymoma (MPE). MPE is a localized and slowly growing, low-grade tumor.
  • Although some ependymomas are of a more anaplastic and malignant type, most of them are not anaplastic.

References


Linked-in.jpg